ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,316.33
0.15%
US Tech 100
18,144.80
0.16%
다우존스 지수
39,984.73
0.19%
Bitcoin
65,219.36
-1.57%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Entasis Therapeutics Holdings Inc (ETTX)

  7. Entasis Therapeutics Holdings Inc (ETTX) 뉴스

ETTX

Entasis Therapeutics (ETTX)

Entasis Therapeutics Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ETTX
일자시간출처헤드라인심볼기업
2022/10/1221:30GlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/2206:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1206:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/1205:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0906:05Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0906:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0905:55Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0905:49Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0821:35Business WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/07/0119:04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1721:11Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1721:09Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1721:04Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
2022/06/1720:58Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
 검색 관련기사 보기:NASDAQ:ETTX

최근 히스토리

USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
FX
USDGBP
US Dollar vs Sterling
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
FX
USDEUR
US Dollar vs Euro
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDJPY
US Dollar vs Yen
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유